Study Stopped
Unable to find eligible participants to participate in the study.
Pathways to Improving Functional Capacity in Older Patients With Chronic Kidney Disease and Cardiovascular Disease
CKD&CAD
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this research study is to study the effect of fish oil and bicarbonate (baking soda) on exercise. In this study fish oil, bicarbonate or both will be compared to placebo to see if study participants increase exercise capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2015
CompletedFirst Posted
Study publicly available on registry
June 16, 2015
CompletedStudy Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedNovember 7, 2017
September 1, 2016
1.4 years
June 10, 2015
November 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline of VO2 peak at 12 weeks
Treadmill during a graded exercise test to exhaustion using a Ramp protocol
12 weeks
Study Arms (4)
Fish Oil and Bicarbonate placebo
ACTIVE COMPARATOR1280mg of fish oil per day and bicarbonate placebo
Fish Oil Placebo and Bicarbonate
ACTIVE COMPARATORfish oil placebo and 1mg of bicarbonate per Kg of body weight per day
Fish Oil and Bicarbonate
EXPERIMENTAL1280mg of fish oil per day and 1mg of bicarbonate per Kg of body weight per day
Fish Oil placebo and Bicarbonate placebo
PLACEBO COMPARATORFish oil placebo and Bicarbonate placebo
Interventions
1280mg of fish oil per day and 1mg of bicarbonate per Kg of body weight per day
1280mg of fish oil per day and bicarbonate placebo (Methylcellulose)
Fish oil placebo (soybean oil) and 1mg of bicarbonate per Kg of body weight per day
Fish oil placebo (soybean oil) and bicarbonate placebo (Methylcellulose)
Eligibility Criteria
You may qualify if:
- Referred to Cardiac Rehabilitation after acute coronary syndromes or percutaneous intervention
- Stage III Chronic kidney disease
- Clinically stable with no mobility conditions that preclude safe walking and able to walk
- No contraindications that will prevent measurement of physical ability and exercise capacity including severe arthritis or musculoskeletal disorders
- knee/hip replacement or spinal surgery in past year
- Approved for participation by Principal Investigator
- Not involved in any other research study or undergoing physical therapy
- Able to provide own transportation to study visits and intervention
- Willing to provide written consent
You may not qualify if:
- Currently taking fish oil supplements
- Advanced malignancy or other medical condition with life expectancy less than 2 years or undergoing active chemotherapy or radiation therapy
- Oxygen-dependent chronic obstructive pulmonary disease
- Normal kidney function or advanced chronic kidney disease (glomerular filtration rate \< 20 mL/min/1.73 m2, on dialysis or dialysis anticipated within 6 months)
- Mini-mental state examination score of ≤ 21 or previously diagnosed dementia or cognitive impairment limiting ability to participate in rehabilitation and follow study protocols
- Chronic anemia with hemoglobin \<10 gm/dl for males, \<9 gm/dl for females or acute anemia requiring transfusion
- Significant impairment from a prior stroke or other neurologic disease or injury that would preclude participation
- Severe peripheral arterial disease that is the primary limitation to ambulation
- Medical condition that would limit exercise
- High risk for non-adherence as determined by screening evaluation
- Patients who have undergone renal transplantation
- Currently taking bicarbonate supplementation
- Current or recent (within the last 3 months) participation in an exercise program
- Carbon Dioxide level greater than the middle of the normal range i.e. 27mmol/L and thus predisposing to metabolic alkalosis
- Moderate 2+ or greater lower extremity edema
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Health Cardiac Rehab
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Killian Robinson, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2015
First Posted
June 16, 2015
Study Start
January 1, 2016
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
November 7, 2017
Record last verified: 2016-09